Fritz H. Schröder

Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Anssi Auvinen, Maciej Kwiatkowski, T. Tammela, 2012, European urology.

The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer

F. Schröder, L. Klotz, N. Shore, 2008, BJU international.

Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.

E. Steyerberg, M. Roobol, Xiaoye Zhu, 2012, European urology.

Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts: results from the prostate biopsy collaborative group

Jenny Donovan, Helmut Klocker, Hans Lilja, 2014, World journal of urology.

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group

Jenny Donovan, Helmut Klocker, Hans Lilja, 2012, World Journal of Urology.